DaVita Total Liabilities and Share Holders Equity 2010-2024 | DVA

DaVita total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • DaVita total liabilities and share holders equity for the quarter ending September 30, 2024 was $17.504B, a 3.4% increase year-over-year.
  • DaVita total liabilities and share holders equity for 2023 was $16.894B, a 0.2% decline from 2022.
  • DaVita total liabilities and share holders equity for 2022 was $16.928B, a 1.13% decline from 2021.
  • DaVita total liabilities and share holders equity for 2021 was $17.121B, a 0.78% increase from 2020.
DaVita Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $16,894
2022 $16,928
2021 $17,121
2020 $16,989
2019 $17,311
2018 $19,110
2017 $18,975
2016 $18,756
2015 $18,515
2014 $17,617
2013 $17,099
2012 $16,015
2011 $8,904
2010 $8,114
2009 $7,558
DaVita Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $17,504
2024-06-30 $17,026
2024-03-31 $17,431
2023-12-31 $16,894
2023-09-30 $16,929
2023-06-30 $16,959
2023-03-31 $16,728
2022-12-31 $16,928
2022-09-30 $16,962
2022-06-30 $17,101
2022-03-31 $17,087
2021-12-31 $17,121
2021-09-30 $17,634
2021-06-30 $17,810
2021-03-31 $17,647
2020-12-31 $16,989
2020-09-30 $17,047
2020-06-30 $19,305
2020-03-31 $17,596
2019-12-31 $17,311
2019-09-30 $17,452
2019-06-30 $19,931
2019-03-31 $22,606
2018-12-31 $19,110
2018-09-30 $19,358
2018-06-30 $19,436
2018-03-31 $18,942
2017-12-31 $18,975
2017-09-30 $19,013
2017-06-30 $19,342
2017-03-31 $19,388
2016-12-31 $18,756
2016-09-30 $18,926
2016-06-30 $18,692
2016-03-31 $18,514
2015-12-31 $18,515
2015-09-30 $18,895
2015-06-30 $18,947
2015-03-31 $18,367
2014-12-31 $17,617
2014-09-30 $18,101
2014-06-30 $17,926
2014-03-31 $17,398
2013-12-31 $17,099
2013-09-30 $16,827
2013-06-30 $16,456
2013-03-31 $16,413
2012-12-31 $16,015
2012-09-30 $10,824
2012-06-30 $9,255
2012-03-31 $9,157
2011-12-31 $8,904
2011-09-30 $8,707
2011-06-30 $8,193
2011-03-31 $8,323
2010-12-31 $8,114
2010-09-30 $7,627
2010-06-30 $7,578
2010-03-31 $7,692
2009-12-31 $7,558
2009-09-30 $7,538
2009-06-30 $7,441
2009-03-31 $7,235
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.272B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00